The Axel Springer-backed share trading platform developer secured $30m that will fund platform development and customer acquisition.

Netease has led a $37.5m round disclosed by multiplayer game developer Theorycraft Games as it emerged from stealth.

Ceres, Dai Nippon Printing, Japan Post Investment, Money Forward, TIS and Toppan all backed the business development, incubation and investment company's latest round.

Telus’ corporate venturing unit has led a $23.7m round for the Canadian online pharmacy as it seeks to take its coverage nationwide.

The Vertex Pharmaceuticals-backed genomic analytics platform developer has now raised approximately $88m in funding altogether.

An unnamed casino operator invested in the sports and esports betting platform developer in around that will support international expansion.

Reliance paid $26.8m to gain majority control of the passive magnetic levitation and propulsion technology developer and now owns 54.5% of its shares.

Oxford Sciences Innovation has returned to back a $30m funding round for Genomics, having previously contributed to a 2018 series B round.

IP Group and V-Bio have backed a round that will support phase 2 trials for a treatment for diabetic macular edema.

Hovione Scientia and Consort Medical-backed Oxular has secured funding that will support phase 2 trials for a treatment for diabetic macular oedema.